Fidson Healthcare Limited 2024 Interim Results For The First Quarter

Fidson Healthcare Limited (FIDSON.ng) Q12024 Interim Report

By Published On: April 30, 2024TYPE: Interim ReportsYear: 2024Period: Q1Country: NigeriaSector: Health

Fidson Healthcare Limited (FIDSON.ng) listed on the Nigerian Stock Exchange under the Health sector has released its 2024 interim results for the first quarter.

For more information about Fidson Healthcare Limited (FIDSON.ng) reports, abridged reports, interim earnings results and earnings presentations visit the Fidson Healthcare Limited (FIDSON.ng) company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for Fidson Healthcare Limited (FIDSON.ng) in the past 12 months, as of 1st April 2024, is US$2.84M (NGN2.27B). An average of US$236.56K (NGN189M) per month.

Fidson Healthcare Limited 2024 interim results for the first quarter

Company Profile

Fidson Healthcare Limited manufactures and sells pharmaceutical and nutraceutical products in Nigeria including over-the-counter, ethical and consumer products. The company produces various drug classes for antacid and ulcer care, anti-diabetic, anti-malaria, anti-diarrhea, anti-psychotic as well as osteo-care, pain relief, colds and flu, thrombo-prophylactics and cardio-vascular products. Fidson Healthcare Limited also produces a range of nutraceuticals (health) products. The company was incorporated in 1995 and its head office is in Shomolu, Nigeria. Fidson Healthcare Limited is listed on the Nigerian Stock Exchange